Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -31.55% is 16% below its 5-year average of -27.13%, around the middle of its 5-year range (-57.85%–-3.03%).
As of the fiscal period ended Friday, July 31, 2026. 19.41% above its 12-month average of -39.15%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-07-31): -31.55%.
RETURN ON EQUITY (ROE)
-31.55%
RETURN ON EQUITY (ROE) AVG TTM
-39.15%
RETURN ON EQUITY (ROE) AVG 3Y
-27.54%
RETURN ON EQUITY (ROE) AVG 5Y
-27.13%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.41%
CURRENT VS 3Y AVG
-14.59%
CURRENT VS 5Y AVG
-16.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+24.89%
vs the sector median at left
High Tide Inc.
Market Cap
$239.01M
Return on Equity (ROE)
-31.55%
TTM Avg
-39.15%
3Y Avg
-27.54%
5Y Avg
-27.13%
Market Cap
$239.02M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$237.57M
Return on Equity (ROE)
-59.27%
TTM Avg
-136.66%
3Y Avg
-113.26%
5Y Avg
-53.68%
Market Cap
$236.82M
Return on Equity (ROE)
-25.20%
TTM Avg
-25.82%
3Y Avg
5.12%
5Y Avg
5.12%
Market Cap
$241.34M
Return on Equity (ROE)
-54.67%
TTM Avg
-46.45%
3Y Avg
-41.29%
5Y Avg
-47.75%
Market Cap
$241.39M
Return on Equity (ROE)
31.90%
TTM Avg
-385.06%
3Y Avg
-191.20%
5Y Avg
-142.10%
Market Cap
$241.94M
Return on Equity (ROE)
N/A
TTM Avg
-1340.59%
3Y Avg
-55.32%
5Y Avg
-61.68%
Market Cap
$235.97M
Return on Equity (ROE)
-1.67%
TTM Avg
19.58%
3Y Avg
23.42%
5Y Avg
29.49%
Market Cap
$235.66M
Return on Equity (ROE)
-118.58%
TTM Avg
62.37%
3Y Avg
-376.78%
5Y Avg
-340.60%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $239.01M | -31.55% | -39.15% | -27.54% | -27.13% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -47.25% | -42.23% | -50.43% | -29.25% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -59.27% | -136.66% | -113.26% | -53.68% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -25.20% | -25.82% | 5.12% | 5.12% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -54.67% | -46.45% | -41.29% | -47.75% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 31.90% | -385.06% | -191.20% | -142.10% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -1340.59% | -55.32% | -61.68% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -1.67% | 19.58% | 23.42% | 29.49% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | -118.58% | 62.37% | -376.78% | -340.60% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 8.59% | 10.64% | 12.16% | 12.16% |
ROE
-31.6%
ROA
-9.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-31 | -31.55% |
| 2026-04-30 | -48.12% |
| 2026-01-31 | -51.41% |
| 2025-10-31 | -57.85% |
| 2025-07-31 | -6.82% |
| 2025-04-30 | -6.78% |
| 2025-01-31 | -4.88% |
| 2024-10-31 | -3.03% |
| 2023-07-31 | -37.37% |
| 2023-04-30 | -38.16% |
| 2023-01-31 | -42.02% |
| 2022-10-31 | -46.41% |
| 2022-07-31 | -12.04% |
| 2022-04-30 | -12.65% |
| 2022-01-31 | -15.61% |
| 2021-10-31 | -23.99% |
| 2021-07-31 | -22.52% |
| 2021-04-30 | -25.90% |
| 2021-01-31 | -38.75% |
| 2020-10-31 | -64.85% |
| 2020-07-31 | -150.58% |
| 2020-04-30 | -366.01% |
| 2020-01-31 | -245.99% |
| 2019-10-31 | -272.03% |
| 2019-07-31 | -59.90% |
| 2019-04-30 | -48.16% |
| 2019-01-31 | -34.16% |
| 2018-10-31 | -19.40% |
| 2018-07-31 | -10.05% |
